Drug patent 2026 patent expiration and generic drug launch

Manage your pharmacy inventory

Find generic entry opportunities

Project your formulary budget

Deep knowledge on
small-molecule drugs and
the global patents
covering them

Anticipate generic drug launch

Drug patents …
… from Kazakhstan to Kalamazoo

Make Better Decisions

Analyze global market entry opportunities
Identify first generic entrants
Obtain formulation and manufacturing information

► See Plans & Pricing

Generated: September 25, 2017

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Delist Req.
Novartis Pharms Corp	PROMACTA	eltrombopag olamine	TABLET;ORAL	022291-005	Nov 16, 2012		RX	Yes	Yes	► Subscribe	► Subscribe		Y
Novartis Pharms Corp	PROMACTA	eltrombopag olamine	TABLET;ORAL	022291-003	Sep 8, 2009		RX	Yes	Yes	► Subscribe	► Subscribe		Y
Novartis Pharms Corp	PROMACTA	eltrombopag olamine	TABLET;ORAL	022291-002	Nov 20, 2008		RX	Yes	No	► Subscribe	► Subscribe		Y
Novartis Pharms Corp	PROMACTA	eltrombopag olamine	TABLET;ORAL	022291-001	Nov 20, 2008		RX	Yes	No	► Subscribe	► Subscribe		Y
Novartis Pharms Corp	PROMACTA	eltrombopag olamine	TABLET;ORAL	022291-004	Oct 20, 2011		RX	Yes	No	► Subscribe	► Subscribe		Y
Novartis Pharms Corp	PROMACTA	eltrombopag olamine	FOR SUSPENSION;ORAL	207027-001	Aug 24, 2015		RX	Yes	Yes	► Subscribe	► Subscribe		Y
Apil	ATELVIA	risedronate sodium	TABLET, DELAYED RELEASE;ORAL	022560-001	Oct 8, 2010	AB	RX	Yes	Yes	► Subscribe	► Subscribe	Y
Takeda Pharms Usa	DEXILANT	dexlansoprazole	CAPSULE, DELAYED RELEASE;ORAL	022287-002	Jan 30, 2009	AB	RX	Yes	Yes	► Subscribe	► Subscribe	Y
Takeda Pharms Usa	DEXILANT	dexlansoprazole	CAPSULE, DELAYED RELEASE;ORAL	022287-001	Jan 30, 2009		RX	Yes	No	► Subscribe	► Subscribe	Y
Takeda Pharms Usa	DEXILANT SOLUTAB	dexlansoprazole	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL	208056-001	Jan 26, 2016		DISCN	Yes	No	► Subscribe	► Subscribe	Y

This preview shows a limited data set Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.